433 related articles for article (PubMed ID: 16889754)
1. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
[TBL] [Abstract][Full Text] [Related]
2. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
Fong WF; Wan CK; Zhu GY; Chattopadhyay A; Dey S; Zhao Z; Shen XL
Planta Med; 2007 Mar; 73(3):212-20. PubMed ID: 17318783
[TBL] [Abstract][Full Text] [Related]
3. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.
Shen X; Chen G; Zhu G; Fong WF
Bioorg Med Chem; 2006 Nov; 14(21):7138-45. PubMed ID: 16875827
[TBL] [Abstract][Full Text] [Related]
4. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
[TBL] [Abstract][Full Text] [Related]
5. Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetate.
Wang C; Zhang JX; Shen XL; Wan CK; Tse AK; Fong WF
Biochem Pharmacol; 2004 Sep; 68(5):843-55. PubMed ID: 15294447
[TBL] [Abstract][Full Text] [Related]
6. Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells--study of structure-activity relationship.
Slaninová I; Brezinová L; Koubíková L; Slanina J
Toxicol In Vitro; 2009 Sep; 23(6):1047-54. PubMed ID: 19531378
[TBL] [Abstract][Full Text] [Related]
7. A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol.
Dey S; Hafkemeyer P; Pastan I; Gottesman MM
Biochemistry; 1999 May; 38(20):6630-9. PubMed ID: 10350482
[TBL] [Abstract][Full Text] [Related]
8. Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2.
Yoo HH; Lee M; Lee MW; Lim SY; Shin J; Kim DH
Planta Med; 2007 May; 73(5):444-50. PubMed ID: 17566147
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract.
Fong WF; Wang C; Zhu GY; Leung CH; Yang MS; Cheung HY
Phytomedicine; 2007 Feb; 14(2-3):160-5. PubMed ID: 16713217
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.
Susa M; Choy E; Yang C; Schwab J; Mankin H; Hornicek F; Duan Z
J Biomol Screen; 2010 Mar; 15(3):287-96. PubMed ID: 20150589
[TBL] [Abstract][Full Text] [Related]
12. Euphorbia factor L1 reverses ABCB1-mediated multidrug resistance involving interaction with ABCB1 independent of ABCB1 downregualtion.
Zhang JY; Mi YJ; Chen SP; Wang F; Liang YJ; Zheng LS; Shi CJ; Tao LY; Chen LM; Chen HB; Fu LW
J Cell Biochem; 2011 Apr; 112(4):1076-83. PubMed ID: 21308736
[TBL] [Abstract][Full Text] [Related]
13. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.
Ramachandra M; Ambudkar SV; Chen D; Hrycyna CA; Dey S; Gottesman MM; Pastan I
Biochemistry; 1998 Apr; 37(14):5010-9. PubMed ID: 9538020
[TBL] [Abstract][Full Text] [Related]
14. Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase.
Rao US
Biochemistry; 1998 Oct; 37(42):14981-8. PubMed ID: 9778376
[TBL] [Abstract][Full Text] [Related]
15. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
[TBL] [Abstract][Full Text] [Related]
16. Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells.
Riganti C; Voena C; Kopecka J; Corsetto PA; Montorfano G; Enrico E; Costamagna C; Rizzo AM; Ghigo D; Bosia A
Mol Pharm; 2011 Jun; 8(3):683-700. PubMed ID: 21491921
[TBL] [Abstract][Full Text] [Related]
17. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
Lee CG; Gottesman MM; Cardarelli CO; Ramachandra M; Jeang KT; Ambudkar SV; Pastan I; Dey S
Biochemistry; 1998 Mar; 37(11):3594-601. PubMed ID: 9530286
[TBL] [Abstract][Full Text] [Related]
20. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
Arora A; Seth K; Kalra N; Shukla Y
Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]